A detailed history of Commonwealth Equity Services, LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 20,103 shares of TAK stock, worth $278,426. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,103
Previous 23,868 15.77%
Holding current value
$278,426
Previous $309,000 7.44%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$13.0 - $15.08 $48,945 - $56,776
-3,765 Reduced 15.77%
20,103 $286,000
Q2 2024

Jul 31, 2024

SELL
$12.6 - $13.67 $23,020 - $24,975
-1,827 Reduced 7.11%
23,868 $309,000
Q1 2024

Apr 29, 2024

SELL
$13.89 - $15.04 $42,406 - $45,917
-3,053 Reduced 10.62%
25,695 $357,000
Q4 2023

Feb 06, 2024

BUY
$13.36 - $15.43 $15,390 - $17,775
1,152 Added 4.17%
28,748 $410,000
Q3 2023

Oct 23, 2023

SELL
$15.03 - $16.32 $41,482 - $45,043
-2,760 Reduced 9.09%
27,596 $427,000
Q2 2023

Aug 10, 2023

SELL
$15.57 - $17.11 $65,705 - $72,204
-4,220 Reduced 12.2%
30,356 $477,000
Q1 2023

May 11, 2023

SELL
$15.28 - $16.48 $8,098 - $8,734
-530 Reduced 1.51%
34,576 $569,000
Q4 2022

Feb 07, 2023

SELL
$12.42 - $15.62 $381,927 - $480,330
-30,751 Reduced 46.69%
35,106 $547,000
Q3 2022

Nov 14, 2022

SELL
$12.8 - $28.65 $27,302 - $61,110
-2,133 Reduced 3.14%
65,857 $854,000
Q2 2022

Jul 19, 2022

SELL
$13.12 - $15.03 $106,022 - $121,457
-8,081 Reduced 10.62%
67,990 $954,000
Q1 2022

May 04, 2022

SELL
$13.54 - $15.35 $42,014 - $47,631
-3,103 Reduced 3.92%
76,071 $1.09 Million
Q4 2021

Jan 31, 2022

SELL
$13.17 - $16.4 $551,730 - $687,045
-41,893 Reduced 34.6%
79,174 $1.08 Million
Q3 2021

Oct 29, 2021

SELL
$16.3 - $17.26 $799,172 - $846,240
-49,029 Reduced 28.82%
121,067 $1.98 Million
Q2 2021

Aug 11, 2021

BUY
$16.55 - $18.64 $517,832 - $583,226
31,289 Added 22.54%
170,096 $2.86 Million
Q1 2021

May 04, 2021

BUY
$16.71 - $19.9 $696,372 - $829,312
41,674 Added 42.9%
138,807 $2.53 Million
Q4 2020

Feb 11, 2021

BUY
$15.39 - $18.97 $1.08 Million - $1.33 Million
70,039 Added 258.5%
97,133 $1.77 Million
Q3 2020

Nov 05, 2020

SELL
$17.1 - $19.19 $53,899 - $60,486
-3,152 Reduced 10.42%
27,094 $483,000
Q2 2020

Aug 12, 2020

SELL
$14.59 - $19.5 $21,739 - $29,055
-1,490 Reduced 4.69%
30,246 $542,000
Q1 2020

May 11, 2020

SELL
$13.02 - $20.31 $51,546 - $80,407
-3,959 Reduced 11.09%
31,736 $481,000
Q4 2019

Feb 05, 2020

BUY
$16.88 - $20.83 $29,826 - $36,806
1,767 Added 5.21%
35,695 $704,000
Q3 2019

Oct 30, 2019

BUY
$16.15 - $17.99 $134,497 - $149,820
8,328 Added 32.53%
33,928 $583,000
Q2 2019

Jul 19, 2019

SELL
$16.58 - $20.49 $165,252 - $204,223
-9,967 Reduced 28.02%
25,600 $453,000
Q1 2019

May 13, 2019

BUY
$16.7 - $21.52 $593,968 - $765,401
35,567 New
35,567 $724,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.